24/7 Patient Assistance: 760-405-8205

Jame Abraham, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Jame Abraham is a medical oncologist from Cleveland, Ohio and he works at Cleveland Clinic. He got his diploma from Calicut Medical College and did his residency in Internal Medicine at the University of Connecticut. Dr. Jame Abraham did a fellowship in Medical Oncology at National Institutes of Health Clinical Center. The doctor is certified in Medical Oncology, Internal Medicine and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Calicut Medical College

    Medical School

    dept_icon

    University of Connecticut

    Residency

    dept_icon

    National Institutes of Health Clinical Center

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    CLEVELAND CLINIC HOSPITAL

    Languages: English/Spanish

    (216) 445-0150

    9500 Euclid Ave Taussig Cancer Institute

    Cleveland, OH 44195

    Read More
  • Publications & Memberships

    Dr. Jame Abraham has contributed to 3 publications.

    Determinants of short and long term outcomes in patients undergoing immediate breast reconstruction following neoadjuvant chemotherapy.

    Wengler, C. A.,Valente, S. A.,AlHilli, Z.,Woody, N. M.,Muntean, J. H.,Abraham, J.,Tendulkar, R. D.,Djohan, R.,O'Rourke, C.,Crowe, J. P.,Grobmyer, S. R.; J Surg Oncol. 2017 Jul 13.

    See more >>

    Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.

    Nangia, J.,Wang, T.,Osborne, C.,Niravath, P.,Otte, K.,Papish, S.,Holmes, F.,Abraham, J.,Lacouture, M.,Courtright, J.,Paxman, R.,Rude, M.,Hilsenbeck, S.,Osborne, C. K.,...; JAMA. 2017 Feb 15.

    See more >>

    Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor.

    Tiwari SR, Mishra P, Abraham J; Clin. Breast Cancer. 2016-10-01.

    See more >>

    Memberships

    American College of Physicians

    American Society of Clinical Oncology